- The total number of your patients who started pregabalin treatment in 2016–17 is shown in the point for reflection above.
- This number is also expressed as a percentage of the total number of your patients who are using pregabalin in 2016–17.
- The number of patients who started with 25 mg strength tablets and the number of patients who started with 75 mg tablets is also provided.
- A patient is considered to have started pregabalin treatment if they had a first prescription for pregabalin in 2016–17 and they did not have a prescription for pregabalin in the 12 months prior to the date of this first prescription.
- The strength of pregabalin prescribed in this first prescription is used for the data.
- This data may give you an indication of the strength of pregabalin that you usually prescribe when you initiate pregabalin treatment.
My numbers do not look as I’d expect, why might this be?
You may have patients using combination strengths of pregabalin, however only the strength recorded on the prescription dispensed most recently will be included in the graph.
For example, you may have a patient using both 75 mg and 150 mg of pregabalin. If the date of supply of pregabalin 75 mg was 1 June 2017, and the date of supply of pregabalin 150 mg was 30 June 2017, then this patient would be included in in the graph as having received 150 mg pregabalin.